Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.

Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years.

Manoff SB, Liss C, Caulfield MJ, Marchese RD, Silber J, Boslego J, Romero-Steiner S, Rajam G, Glass NE, Whitney CG, Carlone GM.

J Infect Dis. 2010 Feb 15;201(4):525-33. doi: 10.1086/651131.

PMID:
20088694
[PubMed - indexed for MEDLINE]
Free Article
2.

Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults.

Musher DM, Manof SB, Liss C, McFetridge RD, Marchese RD, Bushnell B, Alvarez F, Painter C, Blum MD, Silber JL.

J Infect Dis. 2010 Feb 15;201(4):516-24. doi: 10.1086/649839.

PMID:
20092407
[PubMed - indexed for MEDLINE]
Free Article
3.

Immunogenicity of pneumococcal revaccination in patients with chronic disease.

Davidson M, Bulkow LR, Grabman J, Parkinson AJ, Chamblee C, Williams WW, Lanier AP, Schiffman G.

Arch Intern Med. 1994 Oct 10;154(19):2209-14.

PMID:
7944842
[PubMed - indexed for MEDLINE]
4.

Antibody responses to pneumococcal polysaccharide vaccine in Taiwanese patients with chronic obstructive pulmonary disease.

Lai CC, Lee LN, Yu CJ, Hsueh PR, Yang PC, Kuo SH, Luh KT.

J Formos Med Assoc. 2007 Mar;106(3):196-203.

PMID:
17389163
[PubMed - indexed for MEDLINE]
5.

Pneumococcal polysaccharide revaccination: immunoglobulin g seroconversion, persistence, and safety in frail, chronically ill older subjects.

Lackner TE, G Hamilton R, J Hill J, Davey C, Guay DR.

J Am Geriatr Soc. 2003 Feb;51(2):240-5.

PMID:
12558722
[PubMed - indexed for MEDLINE]
6.

Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy.

Shatz DV, Schinsky MF, Pais LB, Romero-Steiner S, Kirton OC, Carlone GM.

J Trauma. 1998 May;44(5):760-5; discussion 765-6.

PMID:
9603075
[PubMed - indexed for MEDLINE]
7.

Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55-74 years living in Alaska: no evidence of hyporesponsiveness.

Hammitt LL, Bulkow LR, Singleton RJ, Nuorti JP, Hummel KB, Miernyk KM, Zanis C, Whaley M, Romero-Steiner S, Butler JC, Rudolph K, Hennessy TW.

Vaccine. 2011 Mar 9;29(12):2287-95. doi: 10.1016/j.vaccine.2011.01.029. Epub 2011 Jan 19.

PMID:
21255685
[PubMed - indexed for MEDLINE]
8.

Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults.

Musher DM, Manoff SB, McFetridge RD, Liss CL, Marchese RD, Raab J, Rueda AM, Walker ML, Hoover PA.

Hum Vaccin. 2011 Sep;7(9):919-28. doi: 10.4161/hv.7.9.15996. Epub 2011 Sep 1.

PMID:
21860256
[PubMed - indexed for MEDLINE]
Free Article
9.

Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil.

Brandão AP, de Oliveira TC, de Cunto Brandileone MC, Gonçalves JE, Yara TI, Simonsen V.

Vaccine. 2004 Dec 21;23(6):762-8. Erratum in: Vaccine. 2005 Mar 14;23(16):2021.

PMID:
15542200
[PubMed - indexed for MEDLINE]
10.

A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.

Landgren O, Björkholm M, Konradsen HB, Söderqvist M, Nilsson B, Gustavsson A, Axdorph U, Kalin M, Grimfors G.

J Intern Med. 2004 Jun;255(6):664-73.

PMID:
15147530
[PubMed - indexed for MEDLINE]
11.

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.

de Roux A, Schmöle-Thoma B, Siber GR, Hackell JG, Kuhnke A, Ahlers N, Baker SA, Razmpour A, Emini EA, Fernsten PD, Gruber WC, Lockhart S, Burkhardt O, Welte T, Lode HM.

Clin Infect Dis. 2008 Apr 1;46(7):1015-23. doi: 10.1086/529142. Erratum in: Clin Infect Dis. 2008 May 1;46(9):1488. Schmöele-Thoma, B [corrected to Schmöle-Thoma, B].

PMID:
18444818
[PubMed - indexed for MEDLINE]
Free Article
12.

V(H)3 antibody response to immunization with pneumococcal polysaccharide vaccine in middle-aged and elderly persons.

Serpa JA, Valayam J, Musher DM, Rossen RD, Pirofski LA, Rodriguez-Barradas MC.

Clin Vaccine Immunol. 2011 Mar;18(3):362-6. doi: 10.1128/CVI.00408-10. Epub 2011 Jan 12.

PMID:
21228144
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Revaccination of adults with spinal cord injury using the 23-valent pneumococcal polysaccharide vaccine.

Waites KB, Canupp KC, Chen YY, DeVivo MJ, Nahm MH.

J Spinal Cord Med. 2008;31(1):53-9.

PMID:
18533412
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Immunogenicity of the 23-valent pneumococcal polysaccharide vaccine in Alaska Native chronic alcoholics compared with nonalcoholic Native and non-Native controls.

McMahon BJ, Parkinson AJ, Bulkow L, Davidson M, Wainwright K, Wolfe P, Schiffman GS.

Am J Med. 1993 Dec;95(6):589-94.

PMID:
8259775
[PubMed - indexed for MEDLINE]
15.

Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity.

Romero-Steiner S, Musher DM, Cetron MS, Pais LB, Groover JE, Fiore AE, Plikaytis BD, Carlone GM.

Clin Infect Dis. 1999 Aug;29(2):281-8.

PMID:
10476727
[PubMed - indexed for MEDLINE]
Free Article
16.

[Persistence of antibodies three years after vaccination with the 23-valent pneumococcal vaccine].

Campins Martí M, Casal Lombos J, Tarragó Asensio D, Rodrigo Anoro MJ, Allepuz Palau A, Callís Bracons L.

An Pediatr (Barc). 2003 Feb;58(2):184-7. Spanish.

PMID:
12628151
[PubMed - indexed for MEDLINE]
Free Article
17.

Immune response to pneumococcal conjugate vaccination in asplenic individuals.

Stanford E, Print F, Falconer M, Lamden K, Ghebrehewet S, Phin N, Baxter D, Helbert M, McCann R, Andrews N, Balmer P, Borrow R, Kaczmarski E.

Hum Vaccin. 2009 Feb;5(2):85-91. Epub 2009 Feb 7.

PMID:
18758242
[PubMed - indexed for MEDLINE]
Free Article
18.

A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults.

Crum-Cianflone NF, Huppler Hullsiek K, Roediger M, Ganesan A, Patel S, Landrum ML, Weintrob A, Agan BK, Medina S, Rahkola J, Hale BR, Janoff EN; Infectious Disease Clinical Research Program HIV Working Group.

J Infect Dis. 2010 Oct 1;202(7):1114-25. doi: 10.1086/656147.

PMID:
20795819
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Pneumococcal polysaccharide 23-valent vaccine: long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults.

Grabenstein JD, Manoff SB.

Vaccine. 2012 Jun 22;30(30):4435-44. doi: 10.1016/j.vaccine.2012.04.052. Epub 2012 Apr 26. Review.

PMID:
22542818
[PubMed - indexed for MEDLINE]
20.

Immunoglobulin G antibody responses to polyvalent pneumococcal vaccine in children in the highlands of Papua New Guinea.

Pomat WS, Lehmann D, Sanders RC, Lewis DJ, Wilson J, Rogers S, Dyke T, Alpers MP.

Infect Immun. 1994 May;62(5):1848-53.

PMID:
8168948
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk